As of 2024-12-11, the Fair Value of Initiator Pharma A/S (INIT.ST) is -2.47 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.05 SEK, the upside of Initiator Pharma A/S is -135.08%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -8.29 | -8.70 | -21.06 | -38.46 | -27.71 | -20.84 |
| YoY growth | 19.51% | -4.95% | -142.07% | -82.60% | 27.95% | -36.43% |
| Market Cap (mil) | 373.84 |
| P/E | |
| Forward P/E |
| EPS | -0.32 |
| Avg earnings growth rate | -36.43% |
| TTM earnings | -16.93 |